Research-Based Product Innovation to Address Critical Unmet Needs of Patients with Inflammatory Bowel Diseases.

Honig, Gerard; Larkin, Paul B; Heller, Caren; Hurtado-Lorenzo, Andrés

Honig, Gerard; Larkin, Paul B; Heller, Caren; Hurtado-Lorenzo, Andrés.

Afiliación

Honig G; Crohn's & Colitis Foundation, New York, NY, USA.
Larkin PB; Crohn's & Colitis Foundation, New York, NY, USA.
Heller C; Crohn's & Colitis Foundation, New York, NY, USA.
Hurtado-Lorenzo A; Crohn's & Colitis Foundation, New York, NY, USA.

Inflamm Bowel Dis ; 27(Suppl 2): S1-S16, 2021 11 15.

Article en En | MEDLINE | ID: mdl-34791292

We highlight the pipeline of investigational therapies, diagnostics, and devices with potential to address pressing unmet needs of patients with inflammatory bowel diseases, including biomarkers for prognosis and treatment response, restoration of eubiosis and mucosal healing, neuromodulation, and improved control of inflammation and disease complications.

Asunto(s)

Antiinflamatorios/uso terapéutico; Necesidades y Demandas de Servicios de Salud; Inmunosupresores/uso terapéutico; Enfermedades Inflamatorias del Intestino/terapia; Biomarcadores/sangre; Colitis; Enfermedad de Crohn; Humanos

Palabras clave

IBD therapies; anti-inflammatory; barrier integrity; behavioral therapy; biomarkers; complications; eubiosis; gut-targeted drug delivery; mucosal healing; neuroinflammation; neuromodulation; precision medicine; preclinical development

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedades Inflamatorias del Intestino / Necesidades y Demandas de Servicios de Salud / Inmunosupresores / Antiinflamatorios Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Inflamm Bowel Dis Asunto de la revista: GASTROENTEROLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google